Tenvie Therapeutics Funding: $200M Raised, Series A (2025)
Tenvie Therapeutics is a Biotech company based in South San Francisco. It has raised $200M in total funding. Latest round: Series A.
Tenvie Therapeutics funding overview
Tenvie Therapeutics is a Biotech company based in South San Francisco. Tenvie Therapeutics has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in January 2025. The round record for Tenvie Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include ARCH Venture Partners, F-Prime Capital, Mubadala Capital, Bain Capital Life Sciences, Digitalis Ventures, Forbion and 4 others. 10 distinct backers are named across the disclosed rounds.
Tenvie Therapeutics at a glance
Total raised
$200M
Latest round
Series A
Latest round date
January 2025
Industry
Biotech
Headquarters
South San Francisco
Notable investors
ARCH Venture Partners, F-Prime Capital, Mubadala Capital, Bain Capital Life Sciences, Digitalis Ventures, Forbion, Pivotal BioVenture Partners, Polaris Partners
Frequently asked about Tenvie Therapeutics funding
How much has Tenvie Therapeutics raised?
Tenvie Therapeutics has raised $200M in total disclosed funding across the rounds on record.
Who has invested in Tenvie Therapeutics?
ARCH Venture Partners, F-Prime Capital, Mubadala Capital, Bain Capital Life Sciences, Digitalis Ventures, Forbion are named among the investors backing Tenvie Therapeutics.
What was the latest Tenvie Therapeutics funding round?
The most recent disclosed round is a Series A, announced in January 2025.
Where is Tenvie Therapeutics based?
Tenvie Therapeutics is based in South San Francisco.
What sector does Tenvie Therapeutics operate in?
Tenvie Therapeutics is tracked under Biotech from South San Francisco, with $200M in disclosed funding.
When did Tenvie Therapeutics last raise?
The last disclosed Tenvie Therapeutics round closed in January 2025 at Series A.
Tenvie Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in South San Francisco below to benchmark round size and investor mix.
